GCM
LLY icon

Genus Capital Management’s Eli Lilly LLY Stock Holding History

Genus Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,716
Closed -$2.41M – 207
2024
Q3 		$2.41M Sell
2,716
-9,454
-78% -$8.5M 0.32% 83
2024
Q2 		$11M Buy
+12,170
New +$9.74M 1.46% 15
2024
Q1 		– Sell
-3,432
Closed -$2M – 307
2023
Q4 		$2M Buy
+3,432
New +$2M 0.29% 102

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Genus Capital Management's LLY Position: Q1 2026 in Review

Genus Capital Management reduced its Eli Lilly (LLY) stake by 25% in Q1 2026, selling an estimated $1.17M and leaving 3,450 shares worth $3.17M. The position accounts for 0.36% of the portfolio, ranked #86.

Genus Capital Management first reported a position in LLY in Q2 2023 and has held it in 6 quarters since. The position peaked at $12.3M in Q2 2023. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Genus Capital Management held 3,450 shares of Eli Lilly worth $3.17M as of Q1 2026.
  • Genus Capital Management sold 1,150 Eli Lilly shares in Q1 2026, an estimated $1.17M.
  • Eli Lilly made up 0.36% of Genus Capital Management's portfolio in Q1 2026, its #86 holding.
  • Genus Capital Management first reported a position in Eli Lilly in Q2 2023 and has held it in 6 quarters since.
  • Genus Capital Management's Eli Lilly position peaked at $12.3M in Q2 2023.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Genus Capital Management's 13F filing for Q1 2026, filed 4 May 2026.